Development of proof of concept for prostate cancer detection: an electrochemical immunosensor based on fullerene-C60 and copper nanoparticles composite film as diagnostic tool

Screening of Prostate-specific antigen (PSA) in human blood is the most common approach to diagnose prostate cancer. The joint application of biology and electrochemistry has shown a tremendous rise in research towards the development of electrochemical diagnostic tools for various diseases. The pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Materials today chemistry 2020-06, Vol.16, p.100257, Article 100257
Hauptverfasser: Suresh, L., Bondili, J.S., Brahman, P.K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 100257
container_title Materials today chemistry
container_volume 16
creator Suresh, L.
Bondili, J.S.
Brahman, P.K.
description Screening of Prostate-specific antigen (PSA) in human blood is the most common approach to diagnose prostate cancer. The joint application of biology and electrochemistry has shown a tremendous rise in research towards the development of electrochemical diagnostic tools for various diseases. The present study demonstrates the development of an effective immunosensing platform incorporating hydroquinone (HQ) immobilized, fullerene-C60 and copper nanoparticles (CuNPs) composite film on glassy carbon electrode (HQ@CuNPs-reduced-fullerene-C60/GCE) for the selective, quick and trace detection of PSA. In order to fabricate immunosensor sequential immobilization of primary antibody (Ab1), blocking agent (bovine serum albumin (BSA)), antigen (prostate-specific antigen (PSA)) and secondary antibody (Ab2) tagged with horseradish peroxide (HRP) was carried out on HQ@CuNPs-reduced-fullerene-C60/GCE. Electrochemical characterization and the signal response of immunosensor were tested using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Due to the synergetic effect of fullerene-C60 and CuNPs, the novel nanocomposite film exhibited excellent catalytic activity towards hydrogen peroxide (H2O2) reduction for greatly amplified immunosensing signals. HQ@CuNPs-fullerene-C60/GCE exhibited a well-defined redox peak and accelerated electrochemical reduction of H2O2 without any interference of dissolved oxygen and false-positive result in phosphate buffer solution (PBS) at pH 7.0. The parameters influencing the electrochemical response were optimized. Under the optimized conditions, wide linearity between PSA concentrations and current responses ranging from 0.005 ng/mL to 20 ng/mL with the lower detection limit of 0.002 ng/mL was obtained at the proposed immunosensor. The clinical applicability of the proposed immunosensor was successfully tested in serum and urine samples. Results revealed that the proposed immunosensor may create new boundaries in the identification of PSA in human blood samples. Illustration of PSA sensing in serum sample via paper based immunosensor as a proof of concept. [Display omitted] •A novel proof of concept was developed for the detection of prostate-specific antigen (PSA) in serum samples.•HQ@CuNPs-fullerene-C60/GCE sensing platform was designed to fabricate immunosensor.•The fabricated immunosensor exhibited excellent sensitivity, special selectivity, and long-term stability.•The immunosensor showed excellent limit of det
doi_str_mv 10.1016/j.mtchem.2020.100257
format Article
fullrecord <record><control><sourceid>elsevier_webof</sourceid><recordid>TN_cdi_webofscience_primary_000537735400031CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468519420300173</els_id><sourcerecordid>S2468519420300173</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-4ae9d929f4a474dadb50af0b3f4b4d9e315db79fb0a93ba378ebb3dc88a491d3</originalsourceid><addsrcrecordid>eNqNkcuKFTEQhhtRcBjnDVxkL31MOumbC0Ha8QIDbmYfcqloDumkSXJGfCsf0Wp6EFeDEJJKpb6qyl9N85rRE6NseHs-rdX8gPXU0W530a4fnzVXnRimtmezeP6P_bK5KeVMMYYyLvrhqvn9ER4gpG2FWElyZMsJd1wmRQNbJS7l3VmqqkCMQmcmFiqY6lN8R1QkEPCS096DNyoQv66XmArEgqhWBSxJkbhLCJAhQrsMFDGLFbYNk0UV06Zy9SZAQee6peKxlvNhJaoQ69V3TIfvpKYUXjUvnAoFbh7P6-b-0-398qW9-_b56_LhrjWcDrUVCmY7d7MTSozCKqt7qhzV3Akt7Ayc9VaPs9NUzVwrPk6gNbdmmpSYmeXXjTjSGvx7yeDklv2q8i_JqNx1l2d56C533eWhO2JvDuwn6OSK8YCC_UVR-J6PI-8FWpxh9PT_0YvHEaDmS7rEiuj7AwXU4MFDlo-49RnHIW3yT3f6B6kxtDM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Development of proof of concept for prostate cancer detection: an electrochemical immunosensor based on fullerene-C60 and copper nanoparticles composite film as diagnostic tool</title><source>Alma/SFX Local Collection</source><creator>Suresh, L. ; Bondili, J.S. ; Brahman, P.K.</creator><creatorcontrib>Suresh, L. ; Bondili, J.S. ; Brahman, P.K.</creatorcontrib><description>Screening of Prostate-specific antigen (PSA) in human blood is the most common approach to diagnose prostate cancer. The joint application of biology and electrochemistry has shown a tremendous rise in research towards the development of electrochemical diagnostic tools for various diseases. The present study demonstrates the development of an effective immunosensing platform incorporating hydroquinone (HQ) immobilized, fullerene-C60 and copper nanoparticles (CuNPs) composite film on glassy carbon electrode (HQ@CuNPs-reduced-fullerene-C60/GCE) for the selective, quick and trace detection of PSA. In order to fabricate immunosensor sequential immobilization of primary antibody (Ab1), blocking agent (bovine serum albumin (BSA)), antigen (prostate-specific antigen (PSA)) and secondary antibody (Ab2) tagged with horseradish peroxide (HRP) was carried out on HQ@CuNPs-reduced-fullerene-C60/GCE. Electrochemical characterization and the signal response of immunosensor were tested using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Due to the synergetic effect of fullerene-C60 and CuNPs, the novel nanocomposite film exhibited excellent catalytic activity towards hydrogen peroxide (H2O2) reduction for greatly amplified immunosensing signals. HQ@CuNPs-fullerene-C60/GCE exhibited a well-defined redox peak and accelerated electrochemical reduction of H2O2 without any interference of dissolved oxygen and false-positive result in phosphate buffer solution (PBS) at pH 7.0. The parameters influencing the electrochemical response were optimized. Under the optimized conditions, wide linearity between PSA concentrations and current responses ranging from 0.005 ng/mL to 20 ng/mL with the lower detection limit of 0.002 ng/mL was obtained at the proposed immunosensor. The clinical applicability of the proposed immunosensor was successfully tested in serum and urine samples. Results revealed that the proposed immunosensor may create new boundaries in the identification of PSA in human blood samples. Illustration of PSA sensing in serum sample via paper based immunosensor as a proof of concept. [Display omitted] •A novel proof of concept was developed for the detection of prostate-specific antigen (PSA) in serum samples.•HQ@CuNPs-fullerene-C60/GCE sensing platform was designed to fabricate immunosensor.•The fabricated immunosensor exhibited excellent sensitivity, special selectivity, and long-term stability.•The immunosensor showed excellent limit of detection as 0.002 ng/mL.•The immunosensor displayed a promising capacity for applying in clinical detection.</description><identifier>ISSN: 2468-5194</identifier><identifier>EISSN: 2468-5194</identifier><identifier>DOI: 10.1016/j.mtchem.2020.100257</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Catalytic activity ; Chemistry ; Chemistry, Multidisciplinary ; Copper nanoparticles ; Fullerene-C60 ; Hydroquinone ; Immunosensor ; Materials Science ; Materials Science, Multidisciplinary ; Physical Sciences ; Prostate-specific antigen ; Science &amp; Technology ; Technology</subject><ispartof>Materials today chemistry, 2020-06, Vol.16, p.100257, Article 100257</ispartof><rights>2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>39</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000537735400031</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c306t-4ae9d929f4a474dadb50af0b3f4b4d9e315db79fb0a93ba378ebb3dc88a491d3</citedby><cites>FETCH-LOGICAL-c306t-4ae9d929f4a474dadb50af0b3f4b4d9e315db79fb0a93ba378ebb3dc88a491d3</cites><orcidid>0000-0001-6532-8558</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids></links><search><creatorcontrib>Suresh, L.</creatorcontrib><creatorcontrib>Bondili, J.S.</creatorcontrib><creatorcontrib>Brahman, P.K.</creatorcontrib><title>Development of proof of concept for prostate cancer detection: an electrochemical immunosensor based on fullerene-C60 and copper nanoparticles composite film as diagnostic tool</title><title>Materials today chemistry</title><addtitle>MATER TODAY CHEM</addtitle><description>Screening of Prostate-specific antigen (PSA) in human blood is the most common approach to diagnose prostate cancer. The joint application of biology and electrochemistry has shown a tremendous rise in research towards the development of electrochemical diagnostic tools for various diseases. The present study demonstrates the development of an effective immunosensing platform incorporating hydroquinone (HQ) immobilized, fullerene-C60 and copper nanoparticles (CuNPs) composite film on glassy carbon electrode (HQ@CuNPs-reduced-fullerene-C60/GCE) for the selective, quick and trace detection of PSA. In order to fabricate immunosensor sequential immobilization of primary antibody (Ab1), blocking agent (bovine serum albumin (BSA)), antigen (prostate-specific antigen (PSA)) and secondary antibody (Ab2) tagged with horseradish peroxide (HRP) was carried out on HQ@CuNPs-reduced-fullerene-C60/GCE. Electrochemical characterization and the signal response of immunosensor were tested using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Due to the synergetic effect of fullerene-C60 and CuNPs, the novel nanocomposite film exhibited excellent catalytic activity towards hydrogen peroxide (H2O2) reduction for greatly amplified immunosensing signals. HQ@CuNPs-fullerene-C60/GCE exhibited a well-defined redox peak and accelerated electrochemical reduction of H2O2 without any interference of dissolved oxygen and false-positive result in phosphate buffer solution (PBS) at pH 7.0. The parameters influencing the electrochemical response were optimized. Under the optimized conditions, wide linearity between PSA concentrations and current responses ranging from 0.005 ng/mL to 20 ng/mL with the lower detection limit of 0.002 ng/mL was obtained at the proposed immunosensor. The clinical applicability of the proposed immunosensor was successfully tested in serum and urine samples. Results revealed that the proposed immunosensor may create new boundaries in the identification of PSA in human blood samples. Illustration of PSA sensing in serum sample via paper based immunosensor as a proof of concept. [Display omitted] •A novel proof of concept was developed for the detection of prostate-specific antigen (PSA) in serum samples.•HQ@CuNPs-fullerene-C60/GCE sensing platform was designed to fabricate immunosensor.•The fabricated immunosensor exhibited excellent sensitivity, special selectivity, and long-term stability.•The immunosensor showed excellent limit of detection as 0.002 ng/mL.•The immunosensor displayed a promising capacity for applying in clinical detection.</description><subject>Catalytic activity</subject><subject>Chemistry</subject><subject>Chemistry, Multidisciplinary</subject><subject>Copper nanoparticles</subject><subject>Fullerene-C60</subject><subject>Hydroquinone</subject><subject>Immunosensor</subject><subject>Materials Science</subject><subject>Materials Science, Multidisciplinary</subject><subject>Physical Sciences</subject><subject>Prostate-specific antigen</subject><subject>Science &amp; Technology</subject><subject>Technology</subject><issn>2468-5194</issn><issn>2468-5194</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqNkcuKFTEQhhtRcBjnDVxkL31MOumbC0Ha8QIDbmYfcqloDumkSXJGfCsf0Wp6EFeDEJJKpb6qyl9N85rRE6NseHs-rdX8gPXU0W530a4fnzVXnRimtmezeP6P_bK5KeVMMYYyLvrhqvn9ER4gpG2FWElyZMsJd1wmRQNbJS7l3VmqqkCMQmcmFiqY6lN8R1QkEPCS096DNyoQv66XmArEgqhWBSxJkbhLCJAhQrsMFDGLFbYNk0UV06Zy9SZAQee6peKxlvNhJaoQ69V3TIfvpKYUXjUvnAoFbh7P6-b-0-398qW9-_b56_LhrjWcDrUVCmY7d7MTSozCKqt7qhzV3Akt7Ayc9VaPs9NUzVwrPk6gNbdmmpSYmeXXjTjSGvx7yeDklv2q8i_JqNx1l2d56C533eWhO2JvDuwn6OSK8YCC_UVR-J6PI-8FWpxh9PT_0YvHEaDmS7rEiuj7AwXU4MFDlo-49RnHIW3yT3f6B6kxtDM</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Suresh, L.</creator><creator>Bondili, J.S.</creator><creator>Brahman, P.K.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-6532-8558</orcidid></search><sort><creationdate>202006</creationdate><title>Development of proof of concept for prostate cancer detection: an electrochemical immunosensor based on fullerene-C60 and copper nanoparticles composite film as diagnostic tool</title><author>Suresh, L. ; Bondili, J.S. ; Brahman, P.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-4ae9d929f4a474dadb50af0b3f4b4d9e315db79fb0a93ba378ebb3dc88a491d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Catalytic activity</topic><topic>Chemistry</topic><topic>Chemistry, Multidisciplinary</topic><topic>Copper nanoparticles</topic><topic>Fullerene-C60</topic><topic>Hydroquinone</topic><topic>Immunosensor</topic><topic>Materials Science</topic><topic>Materials Science, Multidisciplinary</topic><topic>Physical Sciences</topic><topic>Prostate-specific antigen</topic><topic>Science &amp; Technology</topic><topic>Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suresh, L.</creatorcontrib><creatorcontrib>Bondili, J.S.</creatorcontrib><creatorcontrib>Brahman, P.K.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>CrossRef</collection><jtitle>Materials today chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suresh, L.</au><au>Bondili, J.S.</au><au>Brahman, P.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of proof of concept for prostate cancer detection: an electrochemical immunosensor based on fullerene-C60 and copper nanoparticles composite film as diagnostic tool</atitle><jtitle>Materials today chemistry</jtitle><stitle>MATER TODAY CHEM</stitle><date>2020-06</date><risdate>2020</risdate><volume>16</volume><spage>100257</spage><pages>100257-</pages><artnum>100257</artnum><issn>2468-5194</issn><eissn>2468-5194</eissn><abstract>Screening of Prostate-specific antigen (PSA) in human blood is the most common approach to diagnose prostate cancer. The joint application of biology and electrochemistry has shown a tremendous rise in research towards the development of electrochemical diagnostic tools for various diseases. The present study demonstrates the development of an effective immunosensing platform incorporating hydroquinone (HQ) immobilized, fullerene-C60 and copper nanoparticles (CuNPs) composite film on glassy carbon electrode (HQ@CuNPs-reduced-fullerene-C60/GCE) for the selective, quick and trace detection of PSA. In order to fabricate immunosensor sequential immobilization of primary antibody (Ab1), blocking agent (bovine serum albumin (BSA)), antigen (prostate-specific antigen (PSA)) and secondary antibody (Ab2) tagged with horseradish peroxide (HRP) was carried out on HQ@CuNPs-reduced-fullerene-C60/GCE. Electrochemical characterization and the signal response of immunosensor were tested using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Due to the synergetic effect of fullerene-C60 and CuNPs, the novel nanocomposite film exhibited excellent catalytic activity towards hydrogen peroxide (H2O2) reduction for greatly amplified immunosensing signals. HQ@CuNPs-fullerene-C60/GCE exhibited a well-defined redox peak and accelerated electrochemical reduction of H2O2 without any interference of dissolved oxygen and false-positive result in phosphate buffer solution (PBS) at pH 7.0. The parameters influencing the electrochemical response were optimized. Under the optimized conditions, wide linearity between PSA concentrations and current responses ranging from 0.005 ng/mL to 20 ng/mL with the lower detection limit of 0.002 ng/mL was obtained at the proposed immunosensor. The clinical applicability of the proposed immunosensor was successfully tested in serum and urine samples. Results revealed that the proposed immunosensor may create new boundaries in the identification of PSA in human blood samples. Illustration of PSA sensing in serum sample via paper based immunosensor as a proof of concept. [Display omitted] •A novel proof of concept was developed for the detection of prostate-specific antigen (PSA) in serum samples.•HQ@CuNPs-fullerene-C60/GCE sensing platform was designed to fabricate immunosensor.•The fabricated immunosensor exhibited excellent sensitivity, special selectivity, and long-term stability.•The immunosensor showed excellent limit of detection as 0.002 ng/mL.•The immunosensor displayed a promising capacity for applying in clinical detection.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.mtchem.2020.100257</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6532-8558</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2468-5194
ispartof Materials today chemistry, 2020-06, Vol.16, p.100257, Article 100257
issn 2468-5194
2468-5194
language eng
recordid cdi_webofscience_primary_000537735400031CitationCount
source Alma/SFX Local Collection
subjects Catalytic activity
Chemistry
Chemistry, Multidisciplinary
Copper nanoparticles
Fullerene-C60
Hydroquinone
Immunosensor
Materials Science
Materials Science, Multidisciplinary
Physical Sciences
Prostate-specific antigen
Science & Technology
Technology
title Development of proof of concept for prostate cancer detection: an electrochemical immunosensor based on fullerene-C60 and copper nanoparticles composite film as diagnostic tool
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T09%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20proof%20of%20concept%20for%20prostate%20cancer%20detection:%20an%20electrochemical%20immunosensor%20based%20on%20fullerene-C60%20and%20copper%20nanoparticles%20composite%20film%20as%20diagnostic%20tool&rft.jtitle=Materials%20today%20chemistry&rft.au=Suresh,%20L.&rft.date=2020-06&rft.volume=16&rft.spage=100257&rft.pages=100257-&rft.artnum=100257&rft.issn=2468-5194&rft.eissn=2468-5194&rft_id=info:doi/10.1016/j.mtchem.2020.100257&rft_dat=%3Celsevier_webof%3ES2468519420300173%3C/elsevier_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S2468519420300173&rfr_iscdi=true